Are you joining us tomorrow? There’s still time to register for our #PEOF virtual session on February 18, 2025 (14:30 - 16:30 CET). This discussion will bring together patients, nurses, and pathologists to explore how we can advance equitable access to precision oncology and strengthen patient-centered care. We’ll hear from experts on the role of nurses and pathologists in bridging gaps between diagnostics, treatment, and patient engagement. The session will also highlight best practices and practical solutions to improve precision medicine delivery. Hear from speakers: Nicola Fusco (Director, Division of Pathology, IEO Istituto Europeo di Oncologia); Silvija Piškorjanac (Senior Lecturer, Faculty of Medicine, University J.J. Strossmayer Osijek); Umberto Malapelle (Associate Professor Department of Public Health, Università degli Studi di Napoli Federico II); Celia Diez de los Rios (Oncology Advanced Nurse Practitioner); Gloria Okwu (Program Coordinator, Project PINK BLUE, Patient Advocate); Catalina Lopez-Correa (Chief Scientific Officer, Genome Canada Breast Cancer Advocate & Genomics Expert) Register at eu1.hubs.ly/H0gRxcf0 If you know someone who would benefit from this discussion, feel free to share it with your colleagues and network.

Today is #WorldCancerDay, a global reminder that cancer care must be centered around the patients. Nurses and pathologists play a pivotal yet often under-recognized role in bridging the gaps between diagnostics, treatment, and patient engagement—especially in precision oncology. Join us on February 18, 2025, for a Patient Engagement Open Forum virtual session focused on: ✅ Exploring the role of nurses and pathologists in the care pathway, and ways we can empower them to support patients more ✅ Identifying patient priorities in care delivery and what patient-centered care means in precision medicine. ✅ Sharing best practices & scalable solutions for strengthening patient-centered precision medicine delivery. Register now: eu1.hubs.ly/H0gmXMp0 #WorldCancerDay #PeopleCenteredCare #UnitedbyUnique #PEOF

Live for 'From Challenges to Solutions: Empowering Nurses in #PrecisionOncology'. A great way to end the year! Thanks to all participants (registrations from 46 countries 🌍), to Global Power of Oncology Nursing (GPON) for partnering with us & to our speakers incl. @PotisDR

Are you an #oncology nurse? Join us on Dec 18, 2024 for a nurses-only session on #precisionmedicine with GPON! Explore how to take an active role in decision-making, improve collaboration & tackle communication barriers. 📅 Complete the survey to attend eu1.hubs.ly/H0fbJbw0

Heartening to see 3 adapted resources making a difference in #Nigeria helping #patients feel more informed & confident in their care. More perspectives coming soon! Explore the suite: eu1.hubs.ly/H0fblfR0 Interested in adapting these resources? Let us know! @projectpinkblue

Pathologists play a vital role in #personalizedtreatments but face unique challenges. Learn how frameworks like @GA4GH, @myESMO & @FT3Program templates are helping overcome these barriers & improve patient outcomes. Do you know of other impactful initiatives? Tell us! #LCAM

#Nurses play an essential role in the #precisiononcology #patient pathway. They are a vital link. However, they face critical hurdles along the way. Zoom in on key challenges & support needs 👉 Let’s join forces to support HCPs. Reach out today to collaborate! ✉️ #LCAM

Zooming in on nurses & pathologists' crucial role in bringing #personalizedcare to life during #patientpathway. The visuals highlight the gaps & opportunities to enhance their impact. Share these insights with your colleagues & reach out today if you wish to collaborate! #LCAM

During #LungCancer Month, we’ll share the FT3 community’s work to expand HCP capacity for #precisionmedicine, support patient-centered advocacy & scale local initiatives. Stay tuned & share how you’re advancing PM in your community 📸 Meet the change-makers driving this impact!

Interesting insights from @runciecwc as he dives into the Nigerian healthcare context and the impact of adapting educational resources to accelerate the care level activation of personalized medicine for patients and healthcare providers CC @EU_AfricaPerMed

🌟 We're live at the 'Enhancing Patient Involvement in #PersonalizedMedicine' webinar! Excited to join our partners from EuAfrica PerMed as we explore actionable strategies for implementing personalized medicine at the point of care.

At #ESMO2024, @PotisDR highlighted the key role nurses play in transitioning #precisiononcology from personalized treatment to personalized care. This begins with talking to patients. Are you a nurse navigating this shift? Want to learn more? Contact us eu1.hubs.ly/H0cVxqp0

🤔 Advanced technology and medical data can be confusing for patients, their caregivers, and healthcare providers. 👉 Our newest study looked at how well patients and healthcare professionals talk about these complex tests and treatments and what areas need more research to improve communication in this field of personalized cancer care. 👉 Before diving into the paper, take a look at #patientstories, as they allow us to better understand the barriers to accessing targeted treatments, discover best practices, and see key differences between patient experiences in precision medicine: fromtestingtotargetedtreatme… 👀 The paper can be found here: bit.ly/43DyXQn & don't forget to share it with your network! 𝙏𝙝𝙚 𝙥𝙝𝙤𝙩𝙤 𝙞𝙨 𝙛𝙧𝙤𝙢 𝙡𝙖𝙨𝙩 𝙮𝙚𝙖𝙧'𝙨 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙩𝙮 𝙢𝙚𝙚𝙩𝙞𝙣𝙜 𝙞𝙣 𝙈𝙖𝙙𝙧𝙞𝙙 💚

💡 In our community, a belief that keeps us together is that the future of healthcare is personalized, as well as the process of shared decision-making with patients. This approach requires empowered HCPs who can confidently communicate complex biomarker testing (cBT) results to patients. The challenge is that the complexities of comprehensive biomarker testing (cBT) demand advanced genomics knowledge and effective communication skills from HCPs. In this context, medical societies can significantly impact patient care by: ✔Advocating for educational programs that equip HCPs with the knowledge and confidence to navigate cBT and its implications. ✔Integrating shared decision-making models into clinical practice, empowering patients to actively participate in treatment choices based on their cBT results. 👉 These insights are from our recent publication 𝙐𝙣𝙙𝙚𝙧𝙨𝙩𝙖𝙣𝙙𝙞𝙣𝙜 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙗𝙚𝙩𝙬𝙚𝙚𝙣 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙖𝙣𝙙 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙧𝙚𝙜𝙖𝙧𝙙𝙞𝙣𝙜 𝙘𝙤𝙢𝙥𝙧𝙚𝙝𝙚𝙣𝙨𝙞𝙫𝙚 𝙗𝙞𝙤𝙢𝙖𝙧𝙠𝙚𝙧 𝙩𝙚𝙨𝙩𝙞𝙣𝙜 𝙞𝙣 𝙥𝙧𝙚𝙘𝙞𝙨𝙞𝙤𝙣 𝙤𝙣𝙘𝙤𝙡𝙤𝙜𝙮: 𝘼 𝙨𝙘𝙤𝙥𝙞𝙣𝙜 𝙧𝙚𝙫𝙞𝙚𝙬, which you can access here. And share it with your community! bit.ly/43DyXQn

𝘾𝙤𝙢𝙥𝙧𝙚𝙝𝙚𝙣𝙨𝙞𝙫𝙚 𝙗𝙞𝙤𝙢𝙖𝙧𝙠𝙚𝙧 𝙩𝙚𝙨𝙩𝙞𝙣𝙜 (𝙘𝘽𝙏) 𝙞𝙨 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝙗𝙪𝙩 𝙚𝙛𝙛𝙚𝙘𝙩𝙞𝙫𝙚 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙬𝙞𝙩𝙝 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙞𝙨 𝙠𝙚𝙮 𝙩𝙤 𝙖𝙙𝙙𝙧𝙚𝙨𝙨𝙞𝙣𝙜 𝙞𝙩𝙨 𝙘𝙤𝙢𝙥𝙡𝙚𝙭𝙞𝙩𝙞𝙚𝙨. 📕 Our new scoping review addresses this challenge. It explores how clear communication can: ✔Empower patients to understand cBT results and their implications. ✔Navigate uncertainties inherent in cBT findings, like variants of uncertain significance (VUS). ✔Facilitate shared decision-making for personalized treatment plans. ✔Provide ongoing psychological support throughout the process. By optimizing communication, we can ensure patients can make informed decisions and are active partners in their care journey. Read the publication and share your thoughts with us in the comments! bit.ly/43DyXQn

Dear community, we are happy to share our latest literature review, which dives into best practices and hurdles in communication between patients and providers regarding biomarker testing in precision oncology. The paper explores challenges & best practices for discussing: 👉Comprehensive biomarker testing (cBT) 👉Its impact on treatment decisions 👉Educating patients & shared decision-making 👉Reducing potential anxiety Access & share it with your network: bit.ly/43DyXQn

Unlocking #personalizedhealth solutions demands integrating patient engagement & experience data into HTA processes. Neil Bertelsen delves into value assessment challenges for precision medicine. #PrecisionMedicine #ValueAssessment CC @PFMDwithPatient

LAST DAY! Now is the time to recognize that one colleague, peer, or initiative making a difference in #personalizedhealthcare with a focus on #patient engagement 👉 eu1.hubs.ly/H087bbz0 It's easy, pick from the existing network of 6000+ people and initiatives or add yours

Earlier this week @DIA_Europe Lidewij Vat shared insights on real-world evidence (RWE) for decision-making regarding #personalizedhealthcare. Explore the executive summary she presented at eu1.hubs.ly/H0878JT0 #DIAEurope

At @DIA_Europe in Brussels today with FT3 board member Dr. Charles Alessi & Program Director Lidewij Vat, exploring stakeholder views on Highly Innovative Medicines & Real-World Evidence for decision-making. If you're here, let's connect!